Preliminary study shows GLP-1 receptor agonists alter alcohol response, suggesting potential for reducing cravings and ...

Federal research funding cuts threaten UC Davis discoveries in health, agriculture and technology that improve lives ...

Type 1 diabetes wears many faces—an elusive autoimmune disease, a metabolic mess, a chronic condition that requires lifelong ...

Experts weigh in on the most promising AI applications, from diabetic retinopathy screening to smarter insulin delivery, and ...

A large meta-analysis suggests fecal microbiota transplantation may help reduce depressive symptoms, especially in patients ...

A New York Times health reporter explains what makes a good study, and how she knows which papers merit an article.

An expert discusses how the phase 3 LUNA 3 trial demonstrated that rilzabrutinib achieved durable platelet responses in 23% ...

Global Phase III trial has enrolled and randomised over 170 patients, reaching an important milestone as this is above the amount needed to ...

Data demonstrate ATH434 slows disease progression and stabilizes orthostatic hypotension –– New analysis increases overall confidence in the ...

Drinking more than one soda daily may increase liver disease risk by 50–60%. Replacing soda with water could reduce liver ...

Transcutaneous auricular vagus nerve stimulation reduced facial flushing and erythema in patients with rosacea versus sham ...